![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Phorm Corp | LSE:PHRM | London | Ordinary Share | SG9999009278 | ORD NPV (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMPHRM
RNS Number : 2766T
Phorm Inc
02 December 2011
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES ----------------------------------------------- 1. Identity of the issuer or the Phorm, Inc. underlying issuer of existing shares to which voting rights are attached: -------------------------------------- ------------- 2 Reason for the notification (please tick the appropriate box or boxes): -------------------------------------------------------------------------- An acquisition or disposal of voting rights X ------------------------------------------------------------------ ------ An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------------ ------ An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------------ ------ An event changing the breakdown of voting rights ------------------------------------------------------------------ ------ Other (please specify): ------------------ ---------------------------------------------- ------ 3. Full name of person(s) subject Capital Research and Management to the notification obligation: Company ------------------------------------ -------------------------------- 4. Full name of shareholder(s) (if different from 3.): ------------------------------------ -------------------------------- 5. Date of the transaction and date 10 November 2011 on which the threshold is crossed or reached: ------------------------------------ -------------------------------- 6. Date on which issuer notified: 11 November 2011 ------------------------------------ -------------------------------- 7. Threshold(s) that is/are crossed Above 5% or reached: ------------------------------------ -------------------------------- 8. Notified details: ------------------------------------------------------------------------------------------------ A: Voting rights attached to shares ------------------------------------------------------------------------------------------------ Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction if possible using the ISIN CODE ---------------- --------------------- ------------------------------------------------------- Number Number Number Number of voting % of voting rights of of of shares rights Shares Voting Rights ---------------- ---------- --------- ----------- ------------------- --------------------- Indirect Direct Indirect Direct Indirect ---------------- ---------- --------- ----------- ------- ---------- --------- ---------- Ordinary 0 0 4,646,000 4,646,000 6.1543% ---------- --------- ----------- ------- ---------- --------- ---------- US71922A1034 ---------------- ---------- --------- ----------- ------- ---------- --------- ---------- B: Qualifying Financial Instruments ------------------------------------------------------------------------------------ Resulting situation after the triggering transaction ------------------------------------------------------------------------------------ Type of financial Expiration Exercise/ Number of voting % of voting instrument date Conversion rights that rights Period may be acquired if the instrument is exercised/ converted. ------------------ ----------- ------------ ----------------------- ------------ N/A ------------------ ----------- ------------ ----------------------- ------------ C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ----------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------- Type of financial Exercise Expiration Exercise/ Number of voting % of voting instrument price date Conversion rights instrument rights period refers to ------------------ --------- ----------- ------------ ------------------- ---------------- Nominal Delta ------------------ --------- ----------- ------------ ------------------- -------- ------ Total (A+B+C) ------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------ ---------------------------- 4,646,000 6.1543% ------------------------ ---------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: --------------------------------------------------------------------------- Proxy Voting: ------------------------------------ 10. Name of the proxy holder: ------------------------------------ 11. Number of voting rights proxy holder will cease to hold: ------------------------------------ 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------ 13. Additional information: ------------------------------- ----------------- 14. Contact name: Gina Martinez ------------------------------- ----------------- 15. Contact telephone number: +1 213 615 0469 ------------------------------- -----------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLXLLFBFLFEFBK
1 Year Phorm Corp Chart |
1 Month Phorm Corp Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions